Grant: Doctoral Award: Doctoral Foreign Study Award (DFSA)
Direct Payment
$105,000.00
Understanding Elovanoids mechanisms of Neuroprotection in Experimental Ischemic Stroke
FY 2022-23
Summary
More than 400,000 Canadians are living with the effects of stroke, and the health burden is expected to rise as our population ages. Stroke is a devastating disease caused by the sudden interruption of blood flow to the brain which can cause temporary or permanent damage reflected in weakness, difficulty thinking, or even death. The initial site of stroke injury triggers a spreading wave of inflammation that leads to the death of surrounding tissue. We aim to test the effectiveness of a novel class of therapeutics, called elovanoids, at limiting the spread of damage beyond the injury core to protect brain tissue using a rodent model of stroke. Our study will compare young and aged animals to better understand the higher mortality rates and worse quality of life after stroke in the elderly. We will use state-of-the-art technologies to assess changes in cellular lipids and alterations in gene expression in the brain at the single-cell level. By assessing several time points after a stroke, we will define the progression of events that leads to the degeneration of tissues surrounding the infarct. Using a combined lipidomic and genomic analysis approach, we hope to uncover new ways that link lipid signaling to protective genetic responses to injury. The results of this study will lay the foundation for the further development of elovanoids and their precursors as an avenue for potential therapeutics for stroke and other age-related diseases.
Department
Program
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Recipient
Location
Louisiana, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
474124
Name
Ji Jeff X
Region
Louisiana
Country
United States of America
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Understanding Elovanoids mechanisms of Neuroprotection in Experimental Ischemic Stroke
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Keyworddelim
Aging; Glial Phenotypes; Lipid Mediators; Liquid Chromatography-Mass Spectrometry; Maldi-Tof Mass Spectrometry; Mitochondria; Neuroinflammation; Single-Cell Sequencing For Transcriptomic Signature; Spatial Transcriptomics; Stroke Penumbra
Abstract
More than 400,000 Canadians are living with the effects of stroke, and the health burden is expected to rise as our population ages. Stroke is a devastating disease caused by the sudden interruption of blood flow to the brain which can cause temporary or permanent damage reflected in weakness, difficulty thinking, or even death. The initial site of stroke injury triggers a spreading wave of inflammation that leads to the death of surrounding tissue. We aim to test the effectiveness of a novel class of therapeutics, called elovanoids, at limiting the spread of damage beyond the injury core to protect brain tissue using a rodent model of stroke. Our study will compare young and aged animals to better understand the higher mortality rates and worse quality of life after stroke in the elderly. We will use state-of-the-art technologies to assess changes in cellular lipids and alterations in gene expression in the brain at the single-cell level. By assessing several time points after a stroke, we will define the progression of events that leads to the degeneration of tissues surrounding the infarct. Using a combined lipidomic and genomic analysis approach, we hope to uncover new ways that link lipid signaling to protective genetic responses to injury. The results of this study will lay the foundation for the further development of elovanoids and their precursors as an avenue for potential therapeutics for stroke and other age-related diseases.
Competitiondate
202210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ji, Jeff X
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~